The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

EU legal action against AstraZeneca won't help get more vaccines -German health minister

Fri, 23rd Apr 2021 09:46

BERLIN, April 23 (Reuters) - Launching legal action against
AstraZeneca will not help the European Union secure
vaccine doses more quickly, German Health Minister Jens Spahn
said on Friday.

"It is much more important to me that I get these vaccines,"
Spahn told a weekly news conference in Berlin, adding that the
EU should cooperate with AstraZeneca to get as many deliveries
as quickly as possible.

While legal procedures and liability issues will have to be
cleared up, Spahn said they were "not a priority" at this stage
in the pandemic.

The European Commission is working on legal proceedings
against AstraZeneca after the drugmaker cut COVID-19
vaccine deliveries to the European Union, sources familiar with
the matter said on Thursday.
(Reporting by Caroline Copley, editing by Kirsti Knolle)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.